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Abstract
Background: There has been increasing focus on factors predicting the development of chronic musculoskeletal
disorders. For patients already experiencing chronic non-specific low back pain it is also relevant to investigate
which prognostic factors predict recovery. We present the design of a cohort study that aims to determine the
course and prognostic factors for recovery in patients with chronic non-specific low back pain.
Methods/Design: All participating patients were recruited (Jan 2003-Dec 2008) from the same rehabilitation centre
and were evaluated by means of (postal) questionnaires and physical examinations at baseline, during the 2-month
therapy program, and at 5 and 12 months after start of therapy. The therapy protocol at the rehabilitation centre
used a bio-psychosocial approach to stimulate patients to adopt adequate (movement) behaviour aimed at
physical and functional recovery. The program is part of regular care and consists of 16 sessions of 3 hours each,
over an 8-week period (in total 48 hours), followed by a 3-month self-management program. The primary
outcomes are low back pain intensity, disability, quality of life, patient’s global perceived effect of recovery, and
participation in work. Baseline characteristics include information on socio-demographics, low back pain,
employment status, and additional clinical items status such as fatigue, duration of activities, and fear of
kinesiophobia. Prognostic variables are determined for recovery at short-term (5 months) and long-term (12
months) follow-up after start of therapy.
Discussion: In a routine clinical setting it is important to provide patients suffering from chronic non-specific low
back pain with adequate information about the prognosis of their complaint.
Background
In the Netherlands, the annual incidence of back pain in
the general population is estimated at 10-15% [1]. In
1999, chronic non-specific low back pain (CNLBP) was
reported by 16.0% of Dutch working men, by 23.1% of
non-working men, by 17.9% of working women and
27.4% of non-working women [2]. CNLBP has conse-
quences for daily activity, use of health care services and
ability to work. Most people with acute low back pain
recover from their pain and/or disability and return to
work within a few weeks [3]. Up to 3 months the self-
limiting condition improves at a slower pace compared
to the first month of recovery, and after 3 months the
chance of recovery diminishes for patients with CNLBP
[1,3-5]. However, CNLBP can fluctuate over time with
(frequent) recurrences or exacerbations [6,7]. Identifying
the factors that predict the prognosis of CNLBP can
help physicians in the management of patients with
CNLBP. Prognostic factors are suspected to differ
between acute and chronic non-specific low back pain
since the course of these two conditions differs [4,8].
The transition from acute non-specific low back pain to
CNLBP has been well investigated [9-12], whereas
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are scarce.
A recent systematic review investigating which out-
come measurements were used to define recovery of
low back pain in the past 10 years, concluded that
almost every study defined recovery differently [13].
Although pain and disability were the outcome mea-
surements most often used for defining recovery, a
broader perspective may provide a more comprehensive
health profile of the patient [14-16].
Therefore, we present the design of a cohort study
that investigates the course of patients with CNLBP
undergoing treatment in an outpatient rehabilitation
centre. Also investigated are prognostic factors for
recovery using the outcomes low back pain intensity,
low back pain specific disability, generic health status,
patient’s global perceived effect of recovery and work
participation on both the short (5 month) and long (12
month) term.
Methods/Design
Design
This study is a prospective cohort study. Patients
were recruited (from January 2003 - December 2008)
in a multidisciplinary outpatient rehabilitation clinic
the ‘Spine & Joint Centre’ (SJC) in Rotterdam. The
Medical Ethics Committee of SJC approved the study
protocol and all participants provided informed
consent.
Participants
In the present study, low back pain is defined as ‘non-
specific low back pain’, i.e. low back pain without a spe-
cified physical cause, such as nerve root compression
(the radicular syndrome), trauma, infection or the pre-
sence of a tumour. Pain in the lumbosacral region is the
most common symptom in patients with non-specific
low back pain. Pain may also radiate to the gluteal
region or to the thighs, or to both [17].
Patients with CNLBP (low back pain duration > 3
months) not recovering after primary and/or secondary
care were referred by their general practitioner (GP) or
specialist to the SJC for a diagnostic consultation.
The inclusion criteria for this study are:
￿ Men and women aged 18 years or over;
￿ Having CNLBP (i.e. a duration of low back pain for
≥ 3 months);
￿ Previous and insufficient treatment in primary and
secondary care (e.g. physiotherapy);
￿ Signed informed consent.
Exclusion criteria are:
￿ Insufficient knowledge of the Dutch language;
￿ Signs indicating radiculopathy: asymmetric Achilles
tendon reflex and/or (passive) straight leg raise test
restricted by pain in the lower leg; positive magnetic
resonance imaging findings for disc herniation;
￿ Recent (< 6 months) fracture, neoplasm or recent
previous surgery (< 6 months) of the lumbar spine, the
pelvic girdle, the hip joint, or the femur;
￿ Specific causes such ankylosing spondylitis and sys-
temic disease of the locomotor system;
￿ Being pregnant or ≤ 6 months post-partum at the
moment of consultation.
Procedure in the SJC
Based on a bio-psychosocial understanding of CNLBP
the following steps are followed (Figure 1):
Intake (diagnostic consultation)
The intake is a 3-hour session in which: 1) the patient
fills in psychometric questionnaires by computer; 2) a
recording is made of the patient’s strength (Isostation
B200), a motion analysis of forward bending of the lum-
bar pelvic rhythm (video registration) of the trunk, and
3) the patients sees a physician for history taking and
physical examination. The physician may request an
additional consultation with a psychologist and/or man-
ual physiotherapist before deciding on treatment
management.
Patients meeting the inclusion criteria for the SJC are
invited to participate in the multidisciplinary treatment
program. Those not wishing to participate in this pro-
gram are referred to their GP with a letter containing
appropriate recommendations.
Therapy Program
In the therapy protocol, behavioural principles are
applied to encourage patients to adopt adequate normal
behavioural movement aimed at physical recovery. The
program consists of 16 sessions of 3 hours each, over a
2-month period (a total of 48 hours) located in the SJC.
During the program patients are educated to be self-
supporting and to become ‘their own therapist’.A f t e r
this 2-month period, patients are encouraged to con-
tinue the training program independently for at least 3
months, twice a week, in a local, regular health centre
located near their home environment. Five months after
the start of the therapy program (2 months at SJC + 3
months self-supporting activity) the patient has a fol-
low-up meeting.
5-month follow-up after start of therapy
At the 5-month follow-up the patient fills in question-
naires, and discusses the recovery process with a focus
on personal targets with regard to physical training, and
psychological and social factors. A physical examination
takes place and (if required) personal advice is provided
by one of the therapists of the SJC.
12-month follow-up after start of therapy
Via postal correspondence the patient is asked to fill in
the 12-month questionnaires.
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once a week for 4 months (instead of twice a week for
2 months). After the program is completed they are
encouraged to continue their training program for at
least 3 months in a regular health centre. At 7 and 14
months after start of therapy the same follow-up pro-
cedure is performed. The reason for the ‘o n c eaw e e k ’
program is that some patients are unable to visit the
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Figure 1 Study design. ASLR = Active Straight Leg Raise test; PPPP = Posterior Pelvic Pain Provocation test; LDL = longum dorsal sacroiliac
ligament; VAS = Visual Analogue Scale; QBPDS = Quebec Back Pain Disability Scale; SF-36 = Short Form; TSK = Tampa Scale Kinesiophobia.
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problems.
SJC treatment program
Patients are treated in groups of 6 accompanied by 3
therapists. In the first session a personal treatment goal/
plan is established with agreement from the patient.
During the 9
th and 16
th sessions there is a 1:1 patient/
therapist evaluation (in addition to the regular training
program). The remainder of the treatment sessions con-
sist of 1-hour training, a 1-hour group lesson, followed
by another 1-hour training. The training consists of
group training and/or individual coaching. Figure 2 pre-
sents the treatment protocol. The therapists (e.g., a phy-
siotherapist, Mensendieck therapist, psychologist, health
scientist, physician) are trained in the bio-psychosocial
aspects of CNLBP.
The aim of the program is to normalise motion beha-
viour. This is done by modifying the patient’s experience
of movements and increasing the experienced quality of
movements by learning about and training the reduction
of compensatory mechanisms of a physical nature, e.g.
increasing intra-abdominal pressure at low loads,
breathing cessation during loading tasks, and extreme
activity in all superficial muscles. During the program it
is explained that the above-described compensatory
mechanisms are present due to an interaction between
biophysical and psychosocial factors (multidimensional)
such as stress, psychological status and social factors.
All these factors are treated by a multidisciplinary team.
The training starts to increase awareness of excessive
tension of the muscles in trunk and extremities. The
patient is stimulated to take breaks during daily activ-
ities by using tools like time contingent management
and learning about his/her physical load and physical
capacity [18,19]. Breathing techniques are used in com-
bination with a stabilisation program to normalise the
activity of the m. multifidus, m. transversus abdominis
[20-25], diaphragm and pelvic floor (the ‘inner tube sys-
tem’). In a later stage different coordination patterns of
the lumbar-pelvic rhythm by sitting, standing, stooping
and walking are experienced by the patient, and through
strengthening exercises of the ‘global muscles’ (the
‘outer tube system’)t h el o c a ll o a do ft h et r u n ki s
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3.  Lesson: group evaluation and relaxation exercises  
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b. stabilization  program 
c.  cardio program (walking, bicycling, rowing) 
d.  strength excises (force closure) 
e.  daily activities are built up  
3.  Lessons on: pelvic floor and a second pregnancy, preparing oneself for self-training, 
movement in daily life, communication, intimacy and sexuality, anatomy, pain and how 
to handle recidivism 
4.  Building-up daily activities 
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a.  screening by questionnaires, and patient’s goals 
b.  patient receives an information map 
c.  screening if there is a problem with the pelvic floor 
d.  patient is informed of the time contingent load 
e.  personal goals are created for the patient and his/her motivation for the 
therapy 
2.  Introductory lesson (1 hour), a video is made of the patient’s activities and his/her 
strength (rotation and extension) is measured 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Session 16: Evaluation at SJC 
 
1.  Target: evaluation of therapy program and personal goals 
2.  Parts of the therapy: (1 x 45 min) 
a.  physical awareness and relaxation 
b. stabilization  program 
c.  cardio program (walking, bicycling, rowing, cross trainer) 
d.  strength excises (force closure) 
e.  daily activities are built up  
3.  Lesson: group and individual evaluation 
4.  Testing patient’s strength; filling in and discussing questionnaires (QBPDS, TSK, VAS 
pain and fatigue, GPE patient)  
Self-management for 3 months 
1.  Target: continuing therapy program and personal goals twice a week in a local ‘fitness’ 
centre  
2.  Parts of the therapy:  
a.  physical awareness and relaxation 
b. stabilization  program 
c.  cardio program (walking, bicycling, rowing, cross trainer) 
d.  strength excises (force closure) 
e.  daily activities are built up  
3.  Evaluation at the SJC 5 months after start of therapy (2 months SJC and 3 months 
self-management); filling in/discussing questionnaires (QBPDS, TSK, VAS pain and 
fatigue, GPE patient) 
4.  Physical examination: ASLR, PPPP, LDL, load transfer abduction and adduction 
strength 
Figure 2 Flow chart of therapy program. VAS = Visual Analogue Scale; QBPDS = Quebec Back Pain Disability Scale; SF-36 = Short Form;
TSK = Tampa Scale Kinesiophobia; GPE = Global Perceived Effect; ASLR = Active Straight Leg Raise; PPPP = Posterior Pelvic Pain Provocation test;
LDL = Longum Dorsal sacroiliac Ligament.
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Page 4 of 10increased [26-28]. Cardiovascular endurance is trained
by a cardio program. The daily activities of the patients
are built up, depending on the physical load that the
patient can bear.
T h el e s s o n sa i mt om o d i f yt h ep a t i e n t ’s cognitions
with respect to their complaints, thus reinforcing well
behaviours [29]. The group lessons include information
on the patient’s activities, functional anatomy of the
spine, principles of chronic pain, the role and impact of
emotions, communication, and finding the balance
between the load of daily life and physical capacity.
Individual coaching focuses on the specific needs/pro-
blems of the patient. The training is performed in a pro-
gressive sequence adjusted to the patient’s situation and
the clinical experience (estimation) of the therapist.
Additional assistance (as required) is provided by a
manual therapist, psychologist or therapist specialised in
body awareness.
Prognostic factors
Prognostic factors are assessed at intake and at start of
therapy by means of an interview focusing on the
patient’s history, a physical examination, and on ques-
tionnaires. After the 2-month therapy program at SJC,
post-treatment follow-up measurements are scheduled
at 5 and 12 months after start of therapy. In the present
study, the classification into domains as proposed by
Pincus et al. (2008), with one additional domain ‘Physi-
cal characteristics’, is used to order the prognostic fac-
tors [30].
Table 1 lists the prognostic factors. The prognostic
factors include: a) demographic characteristics such as
educational level, marital status, weight, alcohol, smok-
ing and drug consumption; b) clinical status such as
body mass index (BMI), pain below the knee, cause and
duration of complaints, previous rehabilitation, degree
of fatigue [31], low back pain intensity (VAS) [32,33]
and disability (QBPDS). [34,35]; c) psychological charac-
teristics such as fear avoidance (TSK) [36-42] and qual-
ity of life (SF-36) [43]; d) work-related characteristics
such as employment benefits and work participation in
relation to back complaints, and e) physical characteris-
tics such as the mobility of lumbar pelvic rhythm (video
registration) [44], strength (B-200 isostation) [45,46] and
activities of daily living (ADL) consisting of walking, sit-
ting, bicycling and lying. Figure 1 shows the physical
tests that are measured at intake, evaluated at the end
of therapy, and at 5 months after start of therapy. The
reliability and validity of these tests have been estab-
lished. The Active Straight Leg Raising (ASLR) test
[47-49] (0 = not difficult at all, 1 = minimally difficult, 2
= somewhat difficult, 3 = fairly difficult, 4 = very diffi-
cult, 5 = unable to do) is positive when the bilateral
sum score is ≥ 2 (score range 0-10). The posterior pelvic
pain provocation (PPPP) test (0 = no pain, 1 = pain uni-
lateral, 2 = pain bilateral), is positive when the bilateral
sum score is ≥ 2 (0-2). For the ligament sacro-iliacale
longum dorsal (LDL) test [27] (0 = no pain, 1 = com-
plaint of pain without grimace, flinch, or withdrawal
(mild), 2 = pain plus grimace or flinch (moderate), 3 =
the examiner is not able to complete the test because of
withdrawal (unbearable), the score is positive when the
bilateral sum score bilateral is ≥ 2 (score range 0-6).
The load transfer adduction test (score best to worse >
129-0 Newton) and abduction (score best to worse >
196-0 Newton) [50] is measured with a microfet in
Newtons.
T h ec h o i c et oi n c l u d et h e s es pecific variables in the
analyses as potential prognostic factors is based on a lit-
erature review [30], the quality of tests, and clinical
experience in the SJC.
Outcomes
Outcomes are assessed at intake, at the start and end of
therapy, and at 5 and 12 months after start of therapy
using questionnaires (Figure 1). An international group
of back pain researchers recommended a standard bat-
tery of outcome measures to represent the multiple
dimensions of outcome in the field of back pain [14,16].
We measured improvement of the patient with various
measures: 1) pain intensity measured with a visual ana-
logue scale (VAS; at the moment, minimum and maxi-
mum) [51,52], 2) low-back-pain-specific disability is
measured with the Quebec Back Pain Disability Scale
(QBPDS) [53], 3) generic health status. The Short Form
(SF-36) is measured at start of therapy [54-58]. The
three instruments have shown to be reliable, valid and
responsive for a minimal important change (MIC)
[32-35,52,53,59-64]. 4) Global Perceived Effect (GPE) of
the patient is measured with a 5-point scale (1 = much
improved, 2 = slightly improved, 3 = no change, 4 =
slightly worsened, 5 = much worsened) [16]. The GPE is
proven valid [16,65], and 5) work participation. Work
participation is measured by dividing ‘current work
hours’ by ‘former work employment hours’ prior to
CNLBP. No psychometric values are known for this
instrument.
Analyses
Baseline characteristics of the patients are presented as
descriptive statistics. Data on the course of CNLPB
recovery during treatment are presented in graphs and
tables at 5 and 12 months after start of therapy. The
development of a multivariate prognostic model is based
on principles and methods described by Moons and Alt-
man et al. [66-69]. The relationship between potential
prognostic factors and outcome is evaluated using
bivariate and multivariate analyses. For all outcome
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Page 5 of 10Table 1 Baseline characteristics of the study population (n = 1760)
Variables Population (n = 1760) Missing value
Number of female participants 1307(74.3) 0
Age in years: M (SD) 40.1(10.6) 0
Weight (kg): M (SD)* 75.3(14.8) 81(4.6)
Height (cm): M (SD)* 172.2(8.8) 70(4.0)
Demographic factors
Low education * 716(40.7) 71(4.0)
Marital status/living with one adult* 1515(86.1) 46(2.6)
Lifestyle
Alcohol consumers; more than 2 per day* 73(4.1) 326(18.5)
Smoking ‘yes’ * 413(23.5) 326(18.5)
No drug consumers * 1399(79.5) 313(17.8)
Clinical status
Patients with BMI > 25* 783(44.5) 88(5.0)
Duration of complaints in years: M (SD) 7.7(8.8) 0
1 gradual emergence of NLBP 1167(66.3) 30(1.7)
2 sudden emergence of NLBP 563(32.0)
Cause 23(1.3)
1 accident/wrong movement 374(21.3)
2 after physical overload 73(4.1)
3 during pregnancy or after delivery 586(33.3)
4 surgery pelvis/back or after HNP 32(1.8)
5 unknown 672(38.2)
Previous revalidation program* 186(10.6) 101(5.7)
Co-morbidity 275(15.6) 88(5.0)
VAS Pain intensity LBP in mm: M (SD)
1 present pain intensity 55.5(23.0) 5(0.3)
2 minimal pain intensity 34.6(21.7) 13(0.7)
3 maximal pain intensity 80.0(16.2) 13(0.7)
Pain intensity due to CNLBP in the previous 3 months 52(3.0)
1 stable pain intensity 865(49.1)
2 increased pain intensity 723(41.1)
3 decreased pain intensity 120(6.8)
VAS degree of fatigue LBP in mm: M (SD)
1 present fatigue 56.5(26.6) 118(6.7)
2 minimal fatigue 32.2(23.3) 169(9.6)
3 maximal fatigue 77.8(20.4) 169(9.6)
Disability (QBPDS): M (SD) 51.7(15.6) 8(0.5)
Psychological factors
Fear avoidance (TSK): M (SD) 36.7(7.3) 50(2.8)
SF-36 (health-related quality of life)
PCS 31.8(7.1) 493(28.0)
MCS 46.5(10.3) 493(28.0)
Work-related factors
Employment status benefit 924(52.5) 353(20.1)
Work participation 161(9.1)
1 100% working 391(22.2)
2 1-99% working 488(27.7)
3 not working 689(39.1)
4 retired 31(1.8)
Less work due to 460(26.1)
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tigate prognostic factors at 5 and 12 months after start
of therapy. Differences between baseline and follow-up
scores are analyzed using repeated measures analysis of
variance. Logistic regression is used to determine odds
ratios (ORs) of recovery, initially for each variable inde-
pendently and then in a multiple regression model.
Recovery is operationalised into two definitions:
‘improvement in’ [16,33,70] and ‘absolute’ [16,71-73]
recovery for each outcome measurement. All analyses
are conducted with SPSS for Windows (version 18.0).
Results
Baseline Measurements
A total of 2,545 patients [mean age 40.4 (10.9) years;
73.3% women] visited the SJC for an intake consultation
between January 2003 and December 2008. Of these,
1,760 patients [mean age 40.1 (10.6) years; 74.3%
women] with CNLBP met the inclusion criteria, com-
pleted the 2-month therapy program, and were followed
up at 5 and 12 months after start of therapy. Of this lat-
ter group, 96 followed the ‘once a week’ therapy pro-
gram.(with a duration of 4 months). A total of 785
patients [mean age 41.3 (11.5) years; 70.3% women] had
the intake consultation but decided not to start therapy:
reasons given for this included, only wanting the consul-
tation and/or a diagnosis and/or some advice, referred
to another specialist (e.g. psychologist, orthopaedic sur-
geon), decided not to come, travel distance too far, and
unknown reasons.
The distribution of prognostic factors were similar
in both the excluded and included groups regarding
Table 1 Baseline characteristics of the study population (n = 1760) (Continued)
1 complaints 772(43.9)
2 unemployed 19(1.1)
3 different reasons 177(10.1)
4 fully working 332(18.9)
Physical examination
LDL positive
1 left 1373(78.0) 29(1.6)
2 right 1336(75.9) 31(1.8)
Mobility (VR) (degrees in flexion): M (SD)
1 pelvis in flexion 40.7(15.7) 154(8.8)
2 low back in flexion 47.3(14.3) 154(8.8)
3 pelvis+low back in flexion (ROM) 88.0(24.6) 154(8.8)
ASLR positive (sum score ≥ 3)
1 by general practitioner 1442(81.9) 16(0.9)
2 by patient 1217(69.1) 8(0.5)
ADL function - duration > 31 min without pain increase
1 walking 410(23.3) 10(0.6)
2 cycling 312(17.8) 287(16.3)
3 sitting 432(24.5) 13(0.7)
4 lying 1017(57.8) 15(0.9)
5 standing 106(6.1) 9(0.5)
PPPP positive (uni or bilateral) 1110(63.1) 50(2.8)
Load transfer Abduction (Newton): M (SD) 224.9 (96.4) 137 (7.8)
Load transfer Adduction (Newton): M (SD) 172.5 (87.2) 136 (7.7)
B200 Isostation (strength) (Newton): M (SD)
1 extension 81.6(45.8) 107(6.1)
2 flexion 65.2(45.0) 106(6.0)
3 lateroflexion left 68.1(41.2) 106(6.0)
4 lateroflexion right 74.2(39.4) 106(6.0)
5 rotation left 34.6(23.1) 107(6.1)
6 rotation right 33.4(22.5) 108 (6.1)
Values are numbers (percentages) unless stated otherwise.
* these factors were reported when therapy started, or gathered from the personal status; M = mean; SD = standard deviation; BMI = Body Mass Index; NLBP =
non-specific low back pain; VAS = Visual analogue scale; QBPDS = Quebec Back Pain Disability Scale; TSK = Tampa Scale Kinesiophobia; SF-36 = Short Form;P C S
= Physical Component Summary; MCS = Mental Component Summary; SCL-90 = Symptom Checklist; GPE = Global Perceived Effect; ADL = activities of daily
living; VR = video registration; ASLR = Active Straight Leg Raise; PPPP = Posterior Pelvic Pain Provocation test; LDL = longum dorsal sacroiliac ligament.
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gical status, work-related parameters, and physical
examination. Table 1 presents the baseline character-
istics of the 1,760 patients; 74.3% is female with a
(mean) duration of LBP complaints of 7.8 (SD 8.8)
years. Of all patients, 90.2% had stable or increased
low back pain intensity in the 3 months prior to
intake. Pain intensity and disability showed moderate
to severely impaired patients; 43.9% worked less
because of their complaints. Of the 1,760 patients,
1,696 (96.4%) completed the 2-month therapy pro-
gram, 1,564 (88.9%) participated in the 5-month fol-
low-up and 965 (54.8%) completed the 12-month
follow-up after start of therapy.
Discussion
Little information is available on the prognostic factors
for recovery in patients with chronic non-specific low
back pain. The present study is designed to provide
insight into the course and prognostic factors for recov-
ery in patients with CNLBP who are managed in a reha-
bilitation centre.
The study population was recruited from a multidisci-
plinary outpatient rehabilitation clinic (part of regular
care), which leads to a more pragmatic approach regard-
ing the prognosis of patients with CNLBP. In the 6 years
during which patients have been followed for 12 months
after start of therapy, the procedure of data recording
and the follow-up period has been consistent. This lim-
its information bias for the outcome recovery. Another
strength of this study is that use of five domains of
recovery allows to describe and analyse a broader per-
spective of relevant health outcomes for patients with
CNLBP.
The study also has some limitations. First, we are
unable to present the natural (untreated) course of
CNLBP, because all patients receive multidisciplinary
treatment during rehabilitation [74,75]. Also, most
changes in outcome measurements are reported by the
patients themselves, which might lead to some bias. The
existing SJC procedure was maintained with regard to
the follow-up. This probably decreased the response rate
(especially at 12 months after start of therapy) because
some patients were no longer motivated or were not
approached to provide a response if they did not
respond to the postal requests.
Impact of this study
This study provides information on relevant prognostic
factors for recovery, and presents data on the course of
patients with CNLBP following a multidisciplinary reha-
bilitation program.
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